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1. Introduction 
Although frog embryo nuclear RNA is much small- 
er than that of mammals and birds 111, recent work 
has shown that the average size of nuclear RNA mole- 
cules increases during early development of the frog 
embryo [2]. During the same period the quantitative 
level of turnover of nuclear RNA also increases [2]. 
The importance of post-transcriptional nuclear regula- 
tion in development is illustrated by the qualitative 
similarity of nuclear RNA molecules transcribed from 
unique DNA sequences at the early neurula and larval 
stages of developing frog embryos [3]. It is known 
that the thymidine analogue S-bromodeoxyuridine 
(BrdU) can suppress differentiation, or causes dedif- 
ferentiation, in a number of cell types [4]. The effect 
of BrdU upon nuclear RNA size and accumulation of 
labeled cytoplasmic and nuclear RNA was examined 
in this study. 
2. Materials and methods 
The procedures for labeling the frog embryos, 
isolation of nuclei and nuclear RNA, sucrose density 
gradient centrifugation under denaturing conditions 
and estimation of turnover of nuclear RNA have been 
published [2]. Several hundred stage 14 neurula 
embryos [S] were cut into neural plate-dorsal meso- 
derm and belly regions and cultured in Niu-Twitty 
saline [6] or Niu-Twitty saline containing BrdU 
(250 pg/ml) for 1 day. 5-[3H]Uridine (50 PC/ml; 
specific activity 25 Ci/mM) was then added for 0.5 h 
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at the end of the culture period. Neurulation pro- 
gressed normally in both the control and BrdU-treated 
embryos, indicating that BrdU at this concentration 
was not inhibiting development. Nuclear RNA was 
prepared [2] and treated with dimethylsulfoxide to 
insure denaturing conditions [7]. Macaloid (0.5 mgiml) 
and polyvinyl sulfate (40 pg/ml) were present 
during isolation of the nuclei and the RNA in order 
to prevent degradation by RNase. The denatured 
RNA was sedimented through an isokinetic 526.8% 
sucrose gradient (in 0.05 M NaCl, 0.01 M EDTA, 
0.01 M Tris-HCl (pH 7.4) and 0.2% SDS) [8] at 
44 000 rev./min at 20°C for 3.4 h in a Beckman SW 
50.1 rotor. The fractions were collected from the 
bottoms of the tubes and aliquots of each fraction 
counted. Processing intermediates and small nuclear 
RNA species are present in the gradient profiles since 
a gel filtration step was not performed [2]. 
For the investigation of the effect of BrdU upon 
accumulation of labeled cytoplasmic and nuclear 
RNA 40 stage 10 gastrulae, stage 14 neurulae or stage 
18 tailbuds [5] were cut into dorsal ectoderm- 
mesoderm and belly endoderm regions and incubated 
in Niu-Twitty saline containing BrdU at various con- 
centrations and Niu-Twitty saline alone for 1 day for 
gastrulae or 2 days for neurulae and tailbuds. 5-[3H]- 
Uridine (2.5 pa/ml; spec. act. 25 Ci/mmol) was then 
added for 3 h. Nuclear fractions were obtained by 
homogenizing the embryos at 4°C in 0.25 M sucrose- 
0.003 M CaCla containing 1% citric acid, centrifuging 
at 600 X g and washing the nuclear pellet 3-4 times 
with the sucrose medium, followed by 3-4 washes in 
cold 5% trichloroacetic acid (TCA). The cytoplasmic 
fraction was centrifuged at 10 000 X g to pellet pig- 
ment granules and TCA was added to 10% in the 
supernatant fraction. The precipitate then was washed 
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3-4 times with cold 10% TCA. Both TCA precipitates 
were dissolved in 0.3 N KOH and the RNA was 
hydrolysed at 37°C for 18 h. The macromolecules 
were precipitated with cold TCA and centrifugal 
supernatants were collected and counted. 
3. Results and discussion 
The data show that the size range of the nuclear 
RNA molecules isolated from the embryos cultured 
with BrdU (250 pg/ml) is similar to that of the hnRNA 
obtained from the control embryos (fig.1). However, 
there are more copies of the larger hnRNA molecules 
in the BrdU-treated embryos. Similar results were 
obtained in four separate experiments. The inclusion 
of a 32 S denatured RNA marker (yeast killer factor 
RNA labeled with 32P) in a tailbud nuclear RNA prep- 
aration did not alter its sedimentation rate. This 
indicates minimal degradation of the nuclear RNA 
during the isolation procedure. Furthermore, extrac- 
tions of nuclear RNA from a mixture of labeled and 
unlabeled embryos of different stages show that dif- 
ferential degradation does not account for the size 
differences observed in the nuclear RNA at the two 
stages [2]. 
One interpretation of the centrifugation data is 
that in the BrdU-treated embryos there is a decreased 
turnover of hnRNA, thus causing more copies of 
hnRNA to accumulate in the rapidly sedimenting 
fractions. In support of this idea there is a greater 
reduction of labeled cytoplasmic RNA than of 
labeled nuclear RNA in embryos that had been cul- 
tured in BrdU (table 1). This could result from an 
increased turnover or decreased processing of the 
larger hnRNA molecules. 
The mechanism(s) which BrdU substitution for 
thymidine caused certain types of cells to loose their 
differentiated characteristics [4] is presently 
unknown. However, the following data suggest one 
possible mechanism. DNA sequences containing BrdU 
bind Hl histone more strongly [9,10] and have a 
Table 1 
Effect of S-bromodeoxyuridine on accumulation of labeled 
nuclear and cytoplasmic RNA 
Embryonic stage cpm cytoplasmic RNA 
cpm nuclear RNA 
Gastrulae (stage 10) 
Controls E = 1.47 3g = 1.41 
BrdU 125 pg/ml 198 - _ 1.24 177 = 
16o 217 
0.82 
Neurulae (stage 14) 
Controls 
3823 _ 
=- 1.39 
BrdU 500 &g/ml) ‘E = 0.96 
FRACTION NUMBER 
Fig.1. Effect of BrdU upon hnRNA size. Neural plate and 
belly regions of 200 stage 14 neurulae were cultured in Niu- 
Twitty saline or Niu-Twitty saline containing BrdU (250 
fig/ml) for 1 day. At the end of the culture period the 
explants were labeled for 0.5 h with 50 wCi/ml5-[ ‘Hluridine 
(spec. act. 25 Ci/mM). Nuclear RNA was prepared, denatured 
with dimethylsulfoxide and sedimented at 20°C in an iso- 
kinetic 5 -26.8% sucrose gradient for 3.4 h at 44 000 rev./min 
in a Beckman SW 50.1 rotor. The arrows indicate the posi- 
tions of [ 3H]rRNA from Drosophila run on a parallel 
gradient 
Tailbuds (stage 18) 
Controls $$ = 0.549 ‘s = 0.672 
BrdU 50 erg/ml 
500 &ml 
+$ = 0.404 
2 = 0.502 
In each experiment 80 embryos were cut into dorsal ecto- 
dermmesoderm and endoderm regions, half were incubated in 
Niu-Twitty saline and half in Niu-Twitty saline containing 
BrdU for 1 day (gastrulae) or 2 days (neurulae and tailbuds). 
5-[3H]Uridine (2.5 kCi/ml; spec. act. 25 Ci/mM) was added 
for 3 h, nuclear and cytoplasmic fractions obtained and the 
RNA was hydrolyzed and counted 
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higher rrn [ 1 I]. Omission of HI histone in chromatin 
reconstitution experiments allows formation of more 
initiation sites for transcription in vitro [ 121, suggest- 
ing that Hl histone normally blocks initiation sites 
for transcription in vivo. If incorporation of BrdU 
reduces the number of initiation sites for transcrip- 
tion, one result might be transcription of an increased 
number of larger hnRNA molecules. This hypothesis 
presumes that RNA polymerase will ‘read through’ 
such blocked sites, thus increasing the number of 
larger hnRNA molecules. Since the mRNA size range 
is fairly constant during early development in amphi- 
bian embryos [ 131, this implies that a greater turn- 
over of the sequences in the larger hnRNAs would 
occur in order to account for the reduction of size to 
that of the mRNA molecules. The data of table 1 do 
show decreased processing of nuclear RNA in embryo 
explants that did incorporate BrdU into DNA, as 
compared to the controls, and support this possibility. 
However, the data do not obviate the turnover of 
entire hnRNA molecules as well. 
Much lower concentrations of BrdU (1 O-25 pg/ml) 
cause an increase in replicon size in cultured minnow 
and rat hepatoma cells [ 141. This suggests an effect 
upon the initiation sites for replication and lends 
support to the speculation that transcription initiation 
sites are affected in the present work. Higher levels of 
BrdU are used in the present work since this is neces- 
sary to insure penetration of the compound into the 
blocks of cells which are partially covered by a surface 
coat of low permeability. There are other data which 
fit the idea that BrdU affects initiation sites for tran- 
scription. At 10e7 M BrdU is preferentially incorpo- 
rated into intermediate repetitive DNA sequences 
[ 15 ] and hybridizations with RNA labeled with 
[Y-~‘P] ATP and [ 3H] urr me suggest hat transcrip- ‘d’ 
tion initiation sites are rich in repetitive DNA 
sequences [16]. Taken together, this may mean that 
BrdU is preferentially entering transcription initiation 
sites. 
The present study shows that BrdU increases the 
number of larger hnRNA molecules and decreases 
processing of nuclear RNA. Previous work indicated 
an increase in average hnRNA size during early devel- 
opment of the frog embryo and decreased processing 
of nuclear RNA at later stages of development. 
Together these data indicate that post-transcriptional 
processing may play a key role in the accumulation of 
mRNA during embryonic development. 
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